Products Antibodies Monoclonal Antibodies Rabbit anti-Human PD-L1/CD274 Monoclonal Antibody for FC - Q9NZQ7
Rabbit anti-Human PD-L1/CD274 Monoclonal Antibody for FC - Q9NZQ7

Monoclonal Antibodies

Rabbit anti-Human PD-L1/CD274 Monoclonal Antibody for FC - Q9NZQ7

Item Number : CM0007976

Price varies based on specs and customizations


Application
FC
Cross Reactivity
Human
Protein Weight
33kDa
ISO & CE icon

Shipping:

Contact us to get shipping details Enjoy On-time Dispatch Guarantee.

View Specs

Why Choose Us

Easy ordering process, quality products, and dedicated support for your business success.

Easy Process Quality Assured Dedicated Support

Core Product Specifications and Parameters

Parameter Value
Product Name Rabbit anti-Human PD-L1/CD274 mAb
Remarks/Alias B7-H; B7H1; PDL1; PD-L1; hPD-L1; PDCD1L1; PDCD1LG1
Species Human
Gene ID (Human) 29126
Gene ID 29126
Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 1-290 of human PD-L1/CD274 (Q9NZQ7)
Source Rabbit
Category Monoclonal Antibodies
Application FC
Cross Reactivity Human
SWISS Q9NZQ7
Protein Weight 33kDa
Shipping Ice bag

Biological Background: PD-L1/CD274 Function and Localization

  • PD-L1 (Programmed cell death 1 ligand 1, also known as B7-H1) is a member of the immunoglobulin superfamily and functions as a ligand for the inhibitory receptor PD-1.
  • It plays a critical role in maintaining immune tolerance by modulating T-cell activation thresholds and limiting effector responses (PubMed:11015443, PubMed:28813410, PubMed:28813417). Related references: PMID:11015443 PMID:28813410 PMID:28813417
  • Through a yet unidentified activating receptor, PD-L1 may costimulate T-cell subsets that predominantly produce interleukin-10 (IL-10) (PubMed:10581077). Related references: PMID:10581077
  • In response to hypoxia, PD-L1 can translocate to the nucleus via interaction with phosphorylated STAT3, acting as a transcription coactivator to promote GSDMC expression and pyroptosis (PubMed:32929201). Related references: PMID:32929201
  • The PD-1/PD-L1 pathway is widely exploited by tumors to inhibit cytotoxic T lymphocytes and evade anti-tumor immunity, making it a key target for cancer immunotherapy (PubMed:28813410, PubMed:28813417). Related references: PMID:28813410 PMID:28813417
  • Subcellularly, PD-L1 localizes to the cell membrane, early and recycling endosome membranes, and can be secreted or found in the nucleus.
  • Tissue expression is highest in heart, skeletal muscle, placenta, and lung, with broader expression in activated immune cells such as T-cells, B-cells, dendritic cells, and monocytes.

Experimental Guidance and Technical Tips

  • The antibody is conjugated to , making it directly suitable for flow cytometry (FC) without the need for secondary detection reagents.
  • When establishing an FC staining protocol, consider titrating the antibody to determine the optimal concentration for your specific cell type.
  • Validate the antibody in a relevant sample system, such as PD-L1-expressing tumor cell lines or activated human peripheral blood mononuclear cells (PBMCs).
  • As PD-L1 can be upregulated upon activation, ensure appropriate stimulation conditions if analyzing primary immune cells.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio serves as a comprehensive partner for diagnostic manufacturers and research institutes, offering one-stop access to high-quality IVD raw materials—from validated antibody pairs and optimized monoclonal antibodies to bulk ancillary reagents. For immune checkpoint targets like PD-L1, our integrated supply chain and technical consultation support your assay development from concept to clinic, ensuring reliable sourcing for both routine and rare target needs.

View more faqs for this product

Product Datasheet

Rabbit anti-Human PD-L1/CD274 Monoclonal Antibody for FC - Q9NZQ7


REQUEST A QUOTE

Our professional team will reply to you within one business day. Please feel free to contact us!